{
  "actions": [
    {
      "acted_at": "2013-06-11", 
      "committee": "Committee on Finance", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1128-113", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "113", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Carper, Thomas R.", 
      "sponsored_at": "2013-07-23", 
      "state": "DE", 
      "thomas_id": "00179", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Casey, Robert P., Jr.", 
      "sponsored_at": "2013-06-11", 
      "state": "PA", 
      "thomas_id": "01828", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Crapo, Mike", 
      "sponsored_at": "2013-06-11", 
      "state": "ID", 
      "thomas_id": "00250", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Wicker, Roger F.", 
      "sponsored_at": "2013-07-24", 
      "state": "MS", 
      "thomas_id": "01226", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2013-06-11", 
  "number": "1128", 
  "official_title": "A bill to clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr2315-113", 
      "reason": "identical", 
      "type": "bill"
    }
  ], 
  "short_title": "Preserving Access to Orphan Drugs Act of 2013", 
  "sponsor": {
    "district": null, 
    "name": "Toomey, Pat", 
    "state": "PA", 
    "thomas_id": "02085", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2013-06-11", 
  "subjects": [
    "Health", 
    "Health care costs and insurance", 
    "Prescription drugs", 
    "User charges and fees"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2013-06-11", 
    "text": "Preserving Access to Orphan Drugs Act of 2013 - Amends the Patient Protection and Affordable Care Act (PPACA) to exclude any drug or biological product which is approved or licensed by the Food and Drug Administration (FDA) for marketing solely for one or more rare diseases or conditions (orphan drug) from the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million. Makes this Act effective as if included in PPACA."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Preserving Access to Orphan Drugs Act of 2013", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-11-02T07:01:47-04:00"
}